Data imputation [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2020-07-02 13:15 (1418 d 22:56 ago) – Posting: # 21635
Views: 5,096

Hi Martin,

❝ […] adequate handling would require some modeling which seems to be in contradiction to regulatory thinking as NCA is clearly favored in BA/BE studies.


Yep. The EMA’s BE-GL states:

Non-compartmental methods should be used for determination of pharmacokinetic parameters in bioequivalence studies. The use of compartmental methods for the estimation of parameters is not acceptable.


❝ However, I would like to bring a recent paper on this topic to your attention: […]



Why am I not surprised that Thomas recommends kernel density imputation? ;-)
However, PK modeling is not applied. \(\small{\widehat{AUC}}\) is still obtained by NCA, right?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,034 posts in 4,835 threads, 1,647 registered users;
35 visitors (0 registered, 35 guests [including 9 identified bots]).
Forum time: 12:12 CEST (Europe/Vienna)

Give me a fruitful error any time, full of seeds, bursting with its own corrections.
You can keep your sterile truth for yourself.    Vilfredo Pareto

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5